Exact Mass: 369.0548

Exact Mass Matches: 369.0548

Found 39 metabolites which its exact mass value is equals to given mass value 369.0548, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

O1-(2-Thienylcarbonyl)-3-[(2-pyridylthio)methyl]benzene-1-carbohydroximamide

O1-(2-Thienylcarbonyl)-3-[(2-pyridylthio)methyl]benzene-1-carbohydroximamide

C18H15N3O2S2 (369.0606)


   

Bismuth subsalicylate

Bismuth subsalicylate

C7H12BiO4+2 (369.0539)


   

Vidarabine phosphate

Vidarabine phosphate

C10H13N5NaO7P (369.045)


Purines

   

4-Pyridinol, 2-[[[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfinyl]methyl]-3-methoxy-

4-Pyridinol, 2-[[[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfinyl]methyl]-3-methoxy-

C15H13F2N3O4S (369.0595)


   

Sodium 5-O-(hydroxyphosphinato)adenosine

Sodium 5-O-(hydroxyphosphinato)adenosine

C10H13N5NaO7P (369.045)


   

(2-((4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)-4-(PYRIDIN-4-YL)THIAZOL-5-YL)METHANOL

(2-((4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)-4-(PYRIDIN-4-YL)THIAZOL-5-YL)METHANOL

C16H11F4N3OS (369.0559)


   

2-Deoxyguanosine 3-monophosphate sodium salt

2-Deoxyguanosine 3-monophosphate sodium salt

C10H13N5NaO7P (369.045)


   

4-(4-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

4-(4-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

C16H20BrNO4 (369.0576)


   

Boc-trans-DL-b-Pro-4-(3-bromophenyl)-OH

Boc-trans-DL-b-Pro-4-(3-bromophenyl)-OH

C16H20BrNO4 (369.0576)


   

Felodipine 3,5-Dimethyl Ester

Felodipine 3,5-Dimethyl Ester

C17H17Cl2NO4 (369.0535)


   

Dimethyl 4-(3,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyri dinedicarboxylate

Dimethyl 4-(3,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyri dinedicarboxylate

C17H17Cl2NO4 (369.0535)


   

(4R)-4-(ethylamino)-2-(3-hydroxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide-1,1-dioxide

(4R)-4-(ethylamino)-2-(3-hydroxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide-1,1-dioxide

C11H19N3O5S3 (369.0487)


   

SDZ 220-581

SDZ 220-581

C16H17ClNO5P (369.0533)


SDZ 220-581 is an orally active, potent, competitive NMDA receptor antagonist with pKi value of 7.7[1].

   

2-benzylamino-4-benzyloxy-5-bromopyrimidine

2-benzylamino-4-benzyloxy-5-bromopyrimidine

C18H16BrN3O (369.0477)


   

Bromodiphenhydramine hydrochloride

Bromodiphenhydramine hydrochloride

C17H21BrClNO (369.0495)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Bromodiphenhydramine hydrochloride is a potent antihistamine with antimicrobial property. Bromodiphenhydramine hydrochloride inhibits a large number of Gram negative and Gram positive bacteria. Bromodiphenhydramine hydrochloride can be used for cutaneous allergies research[1][2][3].

   

Acetosulfone

N-[5-amino-2-(4-aminophenyl)sulfonyl-phenyl]sulfonylacetamide

C14H15N3O5S2 (369.0453)


C254 - Anti-Infective Agent > C849 - Sulfone Anti-Infective Agent

   

4-(2-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

4-(2-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

C16H20BrNO4 (369.0576)


   

(Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)-N-((5-Methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl)Methyl)acetaMide

(Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)-N-((5-Methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl)Methyl)acetaMide

C13H15N5O4S2 (369.0565)


   

Tris(Cyclopentadienyl)Ytterbium(Iii)

Tris(Cyclopentadienyl)Ytterbium(Iii)

C15H15Yb (369.0562)


   

(r)-4-Ethylamino-3,4-dihydro-2-(2-methoylethyl)-2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide

(r)-4-Ethylamino-3,4-dihydro-2-(2-methoylethyl)-2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide

C11H19N3O5S3 (369.0487)


   

N-({[4-(Aminosulfonyl)phenyl]amino}carbonyl)-4-methylbenzenesulfonamide

N-({[4-(Aminosulfonyl)phenyl]amino}carbonyl)-4-methylbenzenesulfonamide

C14H15N3O5S2 (369.0453)


   

4-[2-[(2,4-Dichlorophenyl)methylthio]-6-methyl-4-pyrimidinyl]morpholine

4-[2-[(2,4-Dichlorophenyl)methylthio]-6-methyl-4-pyrimidinyl]morpholine

C16H17Cl2N3OS (369.0469)


   

5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H13Cl2N5 (369.0548)


   

2-((4-Bromophenyl)phenylmethoxy)ethyl(dimethyl)ammonium chloride

2-((4-Bromophenyl)phenylmethoxy)ethyl(dimethyl)ammonium chloride

C17H21BrClNO (369.0495)


   

sodium;[(2S,3R,4R,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

sodium;[(2S,3R,4R,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

C10H13N5NaO7P (369.045)


   

Toyocamycin phosphate

Toyocamycin phosphate

C12H12N5O7P-2 (369.0474)


   

N-[3-[(4-chlorophenyl)methylthio]-1H-1,2,4-triazol-5-yl]-4-cyanobenzamide

N-[3-[(4-chlorophenyl)methylthio]-1H-1,2,4-triazol-5-yl]-4-cyanobenzamide

C17H12ClN5OS (369.0451)


   

N-{[3-(4-chlorophenyl)-1H-pyrazol-4-yl]methylene}-4-nitrobenzohydrazide

N-{[3-(4-chlorophenyl)-1H-pyrazol-4-yl]methylene}-4-nitrobenzohydrazide

C17H12ClN5O3 (369.0629)


   

2-[[4-(2-chlorophenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]methyl]-1-phthalazinone

2-[[4-(2-chlorophenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]methyl]-1-phthalazinone

C17H12ClN5OS (369.0451)


   

3-(2-furyl)-N-({[4-(4-methylphenyl)-1,3-thiazol-2-yl]amino}carbonothioyl)acrylamide

3-(2-furyl)-N-({[4-(4-methylphenyl)-1,3-thiazol-2-yl]amino}carbonothioyl)acrylamide

C18H15N3O2S2 (369.0606)


   

(R)-beta-(p-bromobenzhydryloxy)ethyldimethylamine hydrochloride

(R)-beta-(p-bromobenzhydryloxy)ethyldimethylamine hydrochloride

C17H21BrClNO (369.0495)


   

N(2),3-etheno-cGMP

N(2),3-etheno-cGMP

C12H12N5O7P (369.0474)


   

(S)-beta-(p-bromobenzhydryloxy)ethyldimethylamine hydrochloride

(S)-beta-(p-bromobenzhydryloxy)ethyldimethylamine hydrochloride

C17H21BrClNO (369.0495)


   

[5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate

[5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate

C12H12N5O7P (369.0474)


   

α-NETA

α-NETA

C16H20INO (369.059)


α-NETA is a potent and noncompetitive choline acetyltransferase (ChA) inhibitor with an IC50 of 9 μM. α-NETA is a potent ALDH1A1 (IC50=0.04 μM) and chemokine-like receptor-1 (CMKLR1) antagonist. α-NETA weakly inhibits cholinesterase (ChE; IC50=84 μM) and acetylcholinesterase (AChE; IC50=300 μM). α-NETA has anti-cancer activity[1][2].

   

1-chloro-n-[2-chloro-5-(3-chloro-2,2-dimethyl-6-methylidenecyclohexyl)-3-methylidenepentyl]methanecarbonimidoyl chloride

1-chloro-n-[2-chloro-5-(3-chloro-2,2-dimethyl-6-methylidenecyclohexyl)-3-methylidenepentyl]methanecarbonimidoyl chloride

C16H23Cl4N (369.0585)


   

1-chloro-n-[(2s)-2-chloro-5-[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylidenepentyl]methanecarbonimidoyl chloride

1-chloro-n-[(2s)-2-chloro-5-[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylidenepentyl]methanecarbonimidoyl chloride

C16H23Cl4N (369.0585)


   

1-chloro-n-{2-chloro-5-[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylidenepentyl}methanecarbonimidoyl chloride

1-chloro-n-{2-chloro-5-[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylidenepentyl}methanecarbonimidoyl chloride

C16H23Cl4N (369.0585)